Show Notes
In this episode of The PJ Pod, we explore the main changes and implications for practice of the National Institute for Health and Care Excellence (NICE)’s chronic heart failure guidance update.
On 3 September 2025, NICE released its updated guidance on ‘Chronic heart failure in adults: diagnosis and management’.
The guidance mentions the role of pharmacy for the first time and has implications for an expanded role for primary care in managing heart failure.
The guidance makes several recommendations, including on the use of combination treatment of the four main types of treatment: angiotensin-converting enzyme inhibitors (ACEIs), beta-blockers (BBs), mineralocorticoid receptor antagonists (MRAs) and sodium-glucose co-transporter-2s (SGLT2s) inhibitors — also known as the four pillars — in the early treatment of heart failure.
In this episode of The PJ Pod, clinical editor Caitlin Killen talks to Paul Wright, consultant cardiovascular pharmacist at Barts Health NHS Trust, to learn more about the guidance and its implications for practice.
This episode was produced by Geoff Marsh.
More from The PJ Pod
For Tase Oputu, becoming the first president of the Royal College of Pharmacy is “the greatest honour of my career”, and she says the move to a royal college is already changing how pharmacy is received by policymakers.
In this episode of Pharmacy Inside Jobs, senior editor, research and learning Alex Clabburn talks to Ed Hindle.
Electronic Prescription System (EPS) nominations connect patients with the pharmacy where they can collect their medication – and often access other services, help and advice while they’re there.
In this episode of Pharmacy Inside Jobs, Joanna Robertson, senior clinical reporter, talks to Mark Stuart, a sports pharmacist whose 25-year career has spanned Olympic, Paralympic and Commonwealth games, as well as anti-doping education at the International Testing Agency.
In this episode of The PJ Pod, senior features editor Siobhan Chan examines how the issue of antimicrobial resistance (AMR) is being communicated outside of traditional clinical and policy settings.